ENDO INTERNATIONAL PLC
ENDO INTERNATIONAL PLC
Share · IE00BJ3V9050 · A1XE6M (XNAS)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - - - 0,00 % 0,00 % -99,99 %

Company Profile for ENDO INTERNATIONAL PLC Share

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; QWO, an injectable treatment for moderate to severe cellulite in the buttocks of adult women; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland. On August 16, 2022, Endo International plc, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.

Invested Funds

The following funds have invested in: ENDO INTERNATIONAL PLC invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
16,52
Percentage (%)
0,04 %

Company Data

Name ENDO INTERNATIONAL PLC
Company Endo International plc
Website https://www.endo.com
Primary Exchange XNAS NASDAQ
WKN A1XE6M
ISIN IE00BJ3V9050
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Mr. Blaise A. Coleman
Country Ireland
Currency USD
Employees 2,9 T
Address Minerva House, 4 Dublin
IPO Date 2018-01-26

Ticker Symbols

Name Symbol
London 0Y5F.L

More Shares

Investors who ENDO INTERNATIONAL PLC hold also have the following shares in their portfolio:
ACTIVISION BLIZZARD INC
ACTIVISION BLIZZARD INC Share
ADTRAN HOLDINGS INC
ADTRAN HOLDINGS INC Share
AMGEN INC
AMGEN INC Share
AUTODESK INC
AUTODESK INC Share
BITCOIN
BITCOIN Crypto
BROADCO INC
BROADCO INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
CORESTATE CAPITAL
CORESTATE CAPITAL Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
DHT S INCNEW
DHT S INCNEW Share
INTEL CORP
INTEL CORP Share
MICROSOFT CORP
MICROSOFT CORP Share
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
WRNTS LKD ORDS INFOSYS 15/02/2022
WRNTS LKD ORDS INFOSYS 15/02/2022 Verbriefte Derivate
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025